NF-κB-Dependent Assembly of an Enhanceosome-Like Complex on the Promoter Region of Apoptosis Inhibitor Bfl-1/A1
暂无分享,去创建一个
Leonard C. Edelstein | C. Gélinas | L. Edelstein | Lynn Lagos | Matthew Simmons | Hemamalini Tirumalai | Céline Gélinas | M. Simmons | L. Lagos | Hemamalini Tirumalai
[1] A. Karsan,et al. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. , 1996, Blood.
[2] T. Waldmann,et al. Activation of human monocytes induces differential resistance to apoptosis with rapid down regulation of caspase-8/FLICE. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[3] J B Lawrence,et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. , 1994, Genes & development.
[4] E. Ainbinder,et al. Mechanism of Rapid Transcriptional Induction of Tumor Necrosis Factor Alpha-Responsive Genes by NF-κB , 2002, Molecular and Cellular Biology.
[5] G. Chinnadurai,et al. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. , 1996, Cancer research.
[6] Interaction and functional collaboration of p300 and C/EBPbeta. , 1997, Molecular and cellular biology.
[7] M. Merika,et al. The role of HMG I(Y) in the assembly and function of the IFN‐β enhanceosome , 1999, The EMBO journal.
[8] C. Y. Wang,et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.
[9] W. Greene,et al. Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.
[10] Jun O. Liu,et al. Integration of calcineurin and MEF2 signals by the coactivator p300 during T‐cell apoptosis , 2000, The EMBO journal.
[11] R. Wickremasinghe,et al. Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. , 1999, Journal of immunology.
[12] Christian Stehlik,et al. Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis , 1998, The Journal of experimental medicine.
[13] M. Merika,et al. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. , 1998, Molecular cell.
[14] Dong-er Zhang,et al. CCAAT/Enhancer-binding Protein Activates the CD14 Promoter and Mediates Transforming Growth Factor β Signaling in Monocyte Development* , 1999, The Journal of Biological Chemistry.
[15] Seamus J. Martin,et al. Inhibition of TNF-induced apoptosis by NF-κB , 1998 .
[16] W. Zong,et al. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .
[17] R. Natarajan,et al. Molecular Mechanisms of Tumor Necrosis Factor α Gene Expression in Monocytic Cells via Hyperglycemia-induced Oxidant Stress-dependent and -independent Pathways* , 2000, The Journal of Biological Chemistry.
[18] P. Neiman,et al. Role of Nr13 in regulation of programmed cell death in the bursa of Fabricius. , 1999, Genes & development.
[19] G. Cheng,et al. Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-κB inhibition , 2000, Oncogene.
[20] M. F. Shannon,et al. Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[21] W. Zong,et al. Rel blocks both anti-Fas- and TNFα-induced apoptosis and an intact Rel transactivation domain is essential for this effect , 1998, Cell Death and Differentiation.
[22] H. Temin,et al. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T , 1986, Cell.
[23] T. Maniatis,et al. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome , 1995, Cell.
[24] G. Nabel,et al. Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator , 1997, Science.
[25] R Grosschedl,et al. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. , 1995, Genes & development.
[26] Q Cheng,et al. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Rustighi,et al. NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C. , 1998, Nucleic acids research.
[28] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[29] T. Gilmore,et al. Control of apoptosis by Rel/NF-κB transcription factors , 1999, Oncogene.
[30] M. Schweder,et al. Human A1, a Bcl-2-related gene, is induced in leukemic cells by cytokines as well as differentiating factors , 1997, Leukemia.
[31] J. V. Falvo,et al. Structure and Function of the Interferon-β Enhanceosome , 1998 .
[32] M. Birrer,et al. Tumor Necrosis Factor Alpha Gene Regulation: Enhancement of C/EBPβ-Induced Activation by c-Jun , 1998, Molecular and Cellular Biology.
[33] M. Augustus,et al. GRS, a novel member of the Bcl-2 gene family, is highly expressed in multiple cancer cell lines and in normal leukocytes , 1997, Oncogene.
[34] Dimitris Thanos,et al. The High Mobility Group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene , 1992, Cell.
[35] J. Diehl,et al. Identification of a C/EBP-Rel complex in avian lymphoid cells , 1994, Molecular and cellular biology.
[36] Y. Sung,et al. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. , 1995, Oncogene.
[37] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[38] T. Maniatis,et al. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. , 1997, Molecular cell.
[39] W. Schaffner,et al. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.
[40] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[41] Marty W. Mayo,et al. NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis , 1999, Molecular and Cellular Biology.
[42] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[43] R. Paro,et al. Analysis of chromatin structure by in vivo formaldehyde cross-linking. , 1997, Methods.
[44] M. Mayo,et al. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. , 2000, Biochimica et biophysica acta.
[45] M. Gerritsen,et al. CREB-binding protein/p300 are transcriptional coactivators of p65. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[46] T. Maniatis,et al. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter. , 1999, Molecular cell.
[47] S. Gerondakis,et al. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. , 1999, Genes & development.
[48] D. Luk,et al. Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts , 1992, Molecular and cellular biology.
[49] Andrew J. Bannister,et al. CBP‐induced stimulation of c‐Fos activity is abrogated by E1A. , 1995, The EMBO journal.
[50] A. Baldwin,et al. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. , 1993, Molecular and cellular biology.
[51] M. Karin,et al. Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.
[52] Dimitris Thanos,et al. Ordered Recruitment of Chromatin Modifying and General Transcription Factors to the IFN-β Promoter , 2000, Cell.
[53] K. Klempnauer,et al. Interaction and functional collaboration of p300 and C/EBPbeta , 1997, Molecular and cellular biology.
[54] A. Baldwin,et al. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B , 1993, Molecular and Cellular Biology.
[55] C. Gélinas,et al. Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB , 1993, Molecular and cellular biology.
[56] A. Baldwin,et al. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction , 1993 .
[57] Dimitris Thanos,et al. Nucleosome Sliding via TBP DNA Binding In Vivo , 2001, Cell.
[58] R. Tjian,et al. Orchestrated response: a symphony of transcription factors for gene control. , 2000, Genes & development.
[59] R. Förster,et al. Downstream Activation of a TATA-less Promoter by Oct-2, Bob1, and NF-κB Directs Expression of the Homing Receptor BLR1 to Mature B Cells* , 1998, The Journal of Biological Chemistry.
[60] E. Clark,et al. The CD40-inducible Bcl-2 family member A1 protects B cells from antigen receptor-mediated apoptosis. , 2000, Cellular immunology.
[61] C Gélinas,et al. c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition , 1997, Molecular and cellular biology.
[62] I. Park,et al. Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines. , 1997, Anticancer research.
[63] M. Tomayko,et al. Long-lived B cells are distinguished by elevated expression of A1. , 1998, Journal of immunology.
[64] A. Baldwin. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. , 2001, The Journal of clinical investigation.
[65] S. Cory,et al. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members , 1999, Cell Death and Differentiation.
[66] M. Berger,et al. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. , 1993, Journal of immunology.
[67] J. Fletcher,et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains , 1995, Cell.
[68] S. Lomvardas,et al. The IFN-beta enhancer: a paradigm for understanding activation and repression of inducible gene expression. , 1999, Cold Spring Harbor symposia on quantitative biology.
[69] D. Green,et al. Inhibition of TNF-induced apoptosis by NF-kappa B. , 1998, Trends in cell biology.
[70] M. Karin,et al. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor , 1994, Nature.
[71] C. Avnstorp,et al. Interleukin‐1 , 1987 .
[72] A. Koj. Initiation of acute phase response and synthesis of cytokines. , 1996, Biochimica et biophysica acta.
[73] A. Karsan,et al. Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1* , 1996, The Journal of Biological Chemistry.
[74] C. Ambrosino,et al. Regulation of HIV-1 Long Terminal Repeats by Interaction of C/EBP(NF-IL6) and NF-κB/Rel Transcription Factors* , 1996, The Journal of Biological Chemistry.
[75] K. Senger,et al. Mechanism by which the IFN-beta enhanceosome activates transcription. , 1999, Proceedings of the National Academy of Sciences of the United States of America.